Position in CCCC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,550,326
+$4,386,505 QoQ
Shares Held
1,188,507
+168.6% QoQ
Ownership
0.966%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 147 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 86%
Shared 10%
None 4%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. CCCC ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in CCCC
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,550,326 | 1,188,507 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,163,821 | 442,518 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $566,276 | 296,480 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $775,420 | 349,289 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $617,598 | 431,888 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $822,647 | 514,155 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,886,151 | 523,931 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,299,643 | 578,885 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,860,296 | 619,112 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,164,182 | 632,091 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $652,619 | 115,508 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $339,681 | 182,625 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $724,305 | 263,384 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,200,156 | 382,216 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,240,712 | 379,782 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $228,703 | 26,078 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||